Nathan Foster, MD
Clinical Cardiac Electrophysiology · Farmington Hills, MINPI 1538373360
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (57.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Abbott accounts for 83.3% of it on its own, with 30 other manufacturers making up the rest. 2025 is the largest year on record at $16,390, more than ten times the $1,359 reported in 2019.
Across 270 payments — averaging $130.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$29K
- Impulse Dynamics (USA) Inc.$3K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$420
- Boston Scientific$349
- Novartis$252
- Medtronic$233
- plus $1K from 25 others
Across 71 payments — averaging $2536.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Impulse Dynamics (USA) Inc.$126K
- Cvrx, Inc.$54K
What the payments were for
- Consulting fees$20,35358%
- Speaking & faculty fees$2,0006%
- Travel & lodging$4,07712%
- Food & beverage$8,80825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 140 | $29,352 |
| Impulse Dynamics (USA) Inc. | 7 | $3,162 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 21 | $420 |
| Boston Scientific | 12 | $349 |
| Novartis | 20 | $252 |
| Medtronic(2 entities) | 8 | $233 |
| Lexicon Pharmaceuticals, Inc. | 1 | $148 |
| Johnson & Johnson | 12 | $148 |
| Biosense Webster, Inc. | 2 | $130 |
| Amgen | 8 | $127 |
| Cvrx, Inc. | 1 | $123 |
| Kestra Medical Technology Services, Inc. | 2 | $106 |
| Boehringer Ingelheim | 6 | $104 |
| Pfizer | 5 | $103 |
| AstraZeneca | 4 | $75 |
| Edwards Lifesciences | 2 | $58 |
| Merck | 2 | $43 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Lundbeck LLC | 2 | $35 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $35 |
| Philips North America LLC | 1 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $26 |
| Cordis US CORP. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
| Chiesi USA, Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $14 |
| Cardiva Medical, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
| Regeneron Healthcare Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMPLATZER AMULET$16,135
- TACTICATH ABLATION CATHETER, SENSOR ENABLED$6,056
- OPTIMIZER$4,166
- AVEIR$1,862
- Accent Pacemaker$1,048
- ENSITE PRECISION$412
- ENSITE$389
- GALLANT$265
- AGILIS$170
- AMPLATZER Occluders$162
- AMPLATZER$153
- Confirm Rx$144
- Unify Assura CRT Defibrillator$144
- Fortify Assura$138
- Barostim Neo System$123
- Merlin Connectivity and Remote$119
- EP-WorkMate Claris System$118
- CoreValve Evolut$100
How this compares
$35,238 in reported general payments places this provider in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
See all clinical cardiac electrophysiology providers in Michigan →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 354 | $377,989 |
| XareltoRivaroxaban | 154 | $180,381 |
| EntrestoSacubitril/Valsartan | 144 | $157,990 |
| JardianceEmpagliflozin | 50 | $51,716 |
| Propafenone Hcl ErPropafenone Hcl | 32 | $4,675 |
| Flecainide Acetate | 75 | $3,589 |
| Metoprolol Succinate | 160 | $2,736 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 59 | $2,557 |
| Propafenone Hcl | 32 | $1,654 |
| Amiodarone Hcl | 51 | $1,468 |
| Carvedilol | 116 | $1,341 |
| Bisoprolol Fumarate | 16 | $904 |
| Spironolactone | 83 | $873 |
| Atorvastatin Calcium | 55 | $862 |
| Bumetanide | 21 | $733 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $103 | $377,989354 claims |
| Johnson & JohnsonXarelto | $148 | $180,381154 claims |
| NovartisEntresto | $252 | $157,990144 claims |
| Boehringer IngelheimJardiance | $104 | $51,71650 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 105 clinical cardiac electrophysiology providers in Michigan.
Other clinical cardiac electrophysiology in Farmington Hills
- Randy LiebermanDetroit$1.2M
- Asim YunusSaginaw$236K
- Jackson LiangAnn Arbor$229K
- Ryan CunnaneAnn Arbor$218K
- Dipak ShahSouthfield$194K
- Rakesh LatchamsettyBrighton$165K
- Ilana KutinskyTroy$138K
- Nishaki MehtaRoyal Oak$133K
- Andre GauriGrand Rapids$126K
- Daniel AlyeshAnn Arbor$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.